Glutamine-depriving conditions compromise the growth and proliferation of activated T cells in vitro [24], whereas restoration of tumor interstitial glutamine levels by tumor-specific GLS1 knockout increases T-cell infiltration and activity in vivo [25]. This evidence concerns the gene GLS and neoplasm.